FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreMain Content
FDA Discusses MQSA and Device Oversight at ACR 2026
May 14, 2026
Radiology devices staff from the FDA led a Lunch and Learn session at ACR 2026, the College’s annual meeting in Washington, DC. The officials focused on key imaging issues, including oversight of AI-enabled software devices, Mammography Quality Standards Act compliance, and how the agency communicates with the public.
During an open-mic session, ACR® members asked questions about AI oversight, ongoing device shortages and ways to engage with the FDA. The officials shared perspectives on using public comment periods, advisory panels and public meetings to provide input to regulators.
ACR staff used the session to urge members to stay or get involved. They pointedly encouraged members to respond to requests for feedback from ACR’s Government Relations Department. This input helps shape ACR’s comments on federal regulatory policies.
For more information about ACR regulatory efforts and FDA policy, contact Michael Peters, ACR Senior Director, Government Affairs.
